124 related articles for article (PubMed ID: 6310625)
1. Chronic sulpiride increased 3H-spiperone binding and calmodulin dependent phosphorylation in rat striatum.
Lau YS; Runice C; Dowd FJ; Anene C
Proc West Pharmacol Soc; 1983; 26():139-43. PubMed ID: 6310625
[No Abstract] [Full Text] [Related]
2. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
Lau YS; Runice C; Dowd F
J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
Lai HC; Carino MA; Horita A
Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
[No Abstract] [Full Text] [Related]
4. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
[No Abstract] [Full Text] [Related]
5. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Köhler C; Ogren SO; Haglund L; Angeby T
Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic sulpiride on striatal spiperone binding.
Bannet J; Gillis S; Ebstein RP; Belmaker RH
Int Pharmacopsychiatry; 1980; 15(6):334-7. PubMed ID: 7298264
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
8. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
Ritzmann RF; Lee JM; Fields JZ
Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
[No Abstract] [Full Text] [Related]
9. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
Köhler C; Haglund L; Ogren SO; Angeby T
J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
[TBL] [Abstract][Full Text] [Related]
10. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
Akiyama K; Sato M; Otsuki S
Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
[TBL] [Abstract][Full Text] [Related]
11. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
Howlett DR; Morris H; Nahorski SR
Br J Pharmacol; 1979 May; 66(1):136P. PubMed ID: 454928
[No Abstract] [Full Text] [Related]
12. Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.
Lautin A; Wazer D; Stanley M; Rotorsen J; Gershon S
Life Sci; 1980 Jul; 27(4):305-16. PubMed ID: 7412477
[No Abstract] [Full Text] [Related]
13. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
Theodorou AE; Hall MD; Jenner P; Marsden CD
J Pharm Pharmacol; 1980 Jun; 32(6):441-4. PubMed ID: 6106685
[No Abstract] [Full Text] [Related]
14. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
Sibley DR; Weinberger S; Segal DS; Creese I
Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
[No Abstract] [Full Text] [Related]
15. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
Howlett DR; Nahorski SR
Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
[No Abstract] [Full Text] [Related]
16. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
Howlett DR; Nahorski SR
Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
[No Abstract] [Full Text] [Related]
17. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
18. Detection of multiple receptors for dopamine.
Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
[No Abstract] [Full Text] [Related]
19. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
Owen F; Cross AJ; Waddington JL; Poulter M; Gamble SJ; Crow TJ
Life Sci; 1980 Jan; 26(1):55-9. PubMed ID: 7189005
[No Abstract] [Full Text] [Related]
20. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
